ArticleFrontiers in physiology2025
Hemodynamic consequences of pressure-flow curve gradient variations in continuous-flow ventricular assist devices.
Article in Frontiers in physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Continuous-flow ventricular assist devices (VADs) have been widely adopted in clinical practice for the treatment of heart failure, but the effect of their non-pulsatile blood flow on microvascular circulation is still debated. Although VADs with a flatter H-Q curve are known to produce greater pulse pressure (PP), other hemodynamic performances have not been systematically compared and analyzed. Methods: This study employed a lumped-parameter cardiopulmonary circulation numerical model to compare the hemodynamic responses of two continuous-flow centrifugal pumps: the Corheart 6 (flatter H-Q curve) and the HeartMate 3 (steeper H-Q curve). Comparisons were conducted across four distinct clinical scenarios: left heart failure, right heart failure, myocardial recovery and acute preload shifts. A quantitative assessment focused on arterial PP, peripheral organ perfusion, ventricular unloading, pump suction risk, and pump thrombosis risk. Results: At the same average pump flow, pumps with a flatter H-Q curve, because of their higher sensitivity to preload, generated higher pump flow pulsatility and greater arterial PP, thereby creating hemodynamic conditions that may theoretically reduce risks associated with flow stasis. However, their ventricular unloading and peripheral organ perfusion were slightly inferior. When pump speed was increased, these pumps achieved ventricular unloading and peripheral organ perfusion comparable to those with steeper H-Q curves while simultaneously yielding even higher arterial PP. In contrast to the static condition, during dynamic events such as acute preload reduction caused by postural changes, VADs with a flatter H-Q curve are better able to maintain systemic perfusion pressure. When applied in right heart failure, right atrium implantation yields superior right ventricular unloading but lower pump flow pulsatility of both pumps. Conclusion: The findings provide references for VAD developers and clinicians for the optimal design and utilization of blood pumps with different H-Q characteristics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.